Trinity Biotech announces EUA submission for Covid-19 ELISA Antibody test

NEXT STORY
Junshi Biosciences and Impact Therapeutics Establish Joint Venture to Develop PARP Inhibitor Senaparib (IMP4297) in China
PREV STORY
Medtronic Begins Post-Market, Real-World Study of the InterStim™ Micro System
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sapience Therapeutics to Present at 2019 BIO CEO & Investor Conference

HARRISON, N.Y., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Sapience Therapeutics, Inc., a biotechnology company ...

author_avatar
NASDAQ Market News

Sun Biopharma, Inc. Announces Initiation of First-Line Combination Study of Sbp-101 With Gemcitabine and Nab-Paclitaxel in Patients With Pancreatic Cancer

MINNEAPOLIS, Jan. 29, 2018 (GLOBE NEWSWIRE) -- – Sun BioPharma, Inc. (OTCQB:SNBP), a clinical ...

author_avatar
NASDAQ Market News

BriaCell Opens Fourth Clinical Site in Advanced Breast Cancer

BERKELEY, Calif. and VANCOUVER, British Columbia, Feb. 06, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics ...

author_avatar
NASDAQ Market News